glp-1 agonists microdose GLP‑1 Microdosing Houston Microdosing GLP-1s: How (and Why)

The dipeptidyl peptidase-4 inhibitor des-fluoro-sitagliptin regulates brown adipose tissue uncoupling protein levels in mice with diet-induced obesity

adults (roughly 1 in 8) report having taken a GLP-1 drug at some point

The short answer: You can begin with your primary care clinician, a specialist in obesity medicine, or in some cases a telehealth provider

On April 21, 2026, a federal judge partly denied Mochis motion to dismiss and allowed Lillys unfair-competition and trademark claims to proceed

Here's a brief timeline: Initial Effects: Many individuals start noticing weight loss effects with tirzepatide relatively early in their treatment, but the exact timeframe can vary due to factors like dosage and individual response